Oric Pharmaceuticals Inc.(ORIC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ORIC Oric Pharmaceuticals Inc.

Post-Mkt 11-03 18:29:41 EST

9.59

+0.52

+5.73%

盘后9.74

+0.15+1.56%

17:50 EST

High10.00	Low9.17	Vol3.56M
Open9.17	D1 Closing9.07	Amplitude9.15%
Mkt Cap992.73M	Tradable Cap850.51M	Total Shares103.52M
T/O34.57M	T/O Rate4.01%	Tradable Shares88.69M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ORIC","market":"US","secType":"STK","nameCN":"Oric Pharmaceuticals Inc.","latestPrice":9.59,"timestamp":1793739600000,"preClose":9.07,"halted":0,"volume":3555376,"hourTrading":{"tag":"盘后","latestPrice":9.74,"preClose":9.59,"latestTime":"17:50 EST","volume":15855,"amount":152061.43638,"timestamp":1793746241470,"change":0.15,"changeRate":0.015641,"amplitude":0.015641},"delay":0,"changeRate":0.057331863285556735,"floatShares":88686700,"shares":103517562,"eps":-1.351255,"marketStatus":"Post-Mkt","change":0.52,"latestTime":"11-03 18:29:41 EST","open":9.17,"high":10,"low":9.17,"amount":34568863.961984,"amplitude":0.09151,"askPrice":9.98,"askSize":196,"bidPrice":9.5,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.351255,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1793754000000},"marketStatusCode":4,"adr":0,"listingDate":1587700800000,"exchange":"NASDAQ","adjPreClose":9.07,"preHourTrading":{"tag":"盘前","latestPrice":9.21,"preClose":9.07,"latestTime":"09:24 EST","volume":2290,"amount":20819.34493,"timestamp":1793715895411,"change":0.14,"changeRate":0.015436,"amplitude":0.196251},"postHourTrading":{"tag":"盘后","latestPrice":9.74,"preClose":9.59,"latestTime":"17:50 EST","volume":15855,"amount":152061.43638,"timestamp":1793746241470,"change":0.15,"changeRate":0.015641,"amplitude":0.015641},"volumeRatio":1.511128,"impliedVol":2.2779,"impliedVolPercentile":0.9522},"requestUrl":"/m/hq/s/ORIC/wiki","defaultTab":"wiki","newsList":[{"id":"2680883777","title":"ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2680883777","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680883777?lang=en_us&edition=fundamental","pubTime":"2026-11-04 05:01","pubTimestamp":1793739660,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov.  03, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing and commercializing tre","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/11/03/3394729/0/en/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678468459","title":"Oric Pharmaceuticals Price Target Maintained with a $26.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2678468459","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678468459?lang=en_us&edition=fundamental","pubTime":"2026-10-28 18:08","pubTimestamp":1793182080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ORIC/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORIC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678036051","title":"Oric Pharmaceuticals (ORIC) Receives a Buy from Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2678036051","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678036051?lang=en_us&edition=fundamental","pubTime":"2026-10-27 21:36","pubTimestamp":1793108173,"startTime":"0","endTime":"0","summary":"In a report released today, from Wedbush maintained a Buy rating on Oric Pharmaceuticals, with a price target of $14.00. Oric Pharmaceuticals has a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oric-pharmaceuticals-oric-receives-a-buy-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oric-pharmaceuticals-oric-receives-a-buy-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ORIC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678117433","title":"Oric Pharmaceuticals selloff on J&J data ‘way overdone,’ says Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2678117433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678117433?lang=en_us&edition=fundamental","pubTime":"2026-10-27 19:40","pubTimestamp":1793101219,"startTime":"0","endTime":"0","summary":"Oric Pharmaceuticals’ (ORIC) 30% selloff following J&J’s (JNJ) JNJ-6143 Phase 1 data appears “way” overdone, as safety and durability remain unprov...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oric-pharmaceuticals-selloff-on-jj-data-way-overdone-says-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oric-pharmaceuticals-selloff-on-jj-data-way-overdone-says-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRUH","LU1066051811.HKD","ORIC","LU0912757837.SGD","LU0640476718.USD","VHT","JNJ","GDOC","MEDX","RXL","LU0545562505.USD","JDOC","IE000BZT7R73.USD","SG9999001176.USD","IXJ","IE0000B7K699.USD","LU0345769128.USD","LU0203345920.USD","PJP","LU2896262040.SGD","FTXH","LU0289961442.SGD","LU1221951046.USD","IE00BVYPNW00.USD","IE00BZ1G4Q59.USD","BMED","LU1280957306.USD","IE00BGHQF631.EUR","IE00BVYPNV92.GBP","LU0124676726.USD","LU1914381329.SGD","LU2471134796.USD","LU0689626769.HKD","LU0114720955.EUR","LU1778281490.HKD","IHE","BK4532","LU0545039389.USD","IE00BSNM7G36.USD","LU0234570918.USD","LU1244550494.USD","IE00B19Z3B42.SGD","LU1935042991.SGD","LU1430594728.SGD","LU0345769631.USD","FHLC","IYH","LU0787776722.HKD","LU1043141123.HKD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678812474","title":"Wedbush Adjusts Price Target on ORIC Pharmaceuticals to $14 From $17, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2678812474","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678812474?lang=en_us&edition=fundamental","pubTime":"2026-10-27 17:08","pubTimestamp":1793092088,"startTime":"0","endTime":"0","summary":"ORIC Pharmaceuticals Inc (ORIC) has an average rating of buy and mean price target of $21.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ORIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678125438","title":"US Research Roundup- Clearwater Paper, Molina Healthcare, Qualys","url":"https://stock-news.laohu8.com/highlight/detail?id=2678125438","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678125438?lang=en_us&edition=fundamental","pubTime":"2026-10-27 15:41","pubTimestamp":1793086888,"startTime":"0","endTime":"0","summary":"US RESEARCH ROUNDUP- Clearwater Paper, Molina Healthcare, QualysOct 27 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several US-listed companies including Clearw","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nL5N46D0FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCBC","ASB","EINC","FRST","COLB","REM","RPD","ENFR","LFST","CHCO","FCG","TRUN","MTCH","GDX","ORIC","BFST","LKFN","TEXU","BOH","CDNS","BRBR","NBBK","NEM","EIPI","COP","CRWV","GBCI","MC","CRAK","PAYC","OLLI","OXY","DK","CEG","EQT","HBT","BSRR","CLW","DINO","PBF","SRCE","MPB","KMI","VDE","MOH","QLYS","RITM","CACI","IYE","FLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678787149","title":"Oric Pharmaceuticals, Inc. : Wedbush Cuts Target Price to $14 from $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2678787149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678787149?lang=en_us&edition=fundamental","pubTime":"2026-10-27 11:11","pubTimestamp":1793070691,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nFWN46C27M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ORIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678190966","title":"Oric Pharmaceuticals is Maintained at Buy by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2678190966","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678190966?lang=en_us&edition=fundamental","pubTime":"2026-10-27 00:55","pubTimestamp":1793033700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ORIC/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORIC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678192910","title":"Oric Pharmaceuticals drops after J&J presents prostate cancer drug data","url":"https://stock-news.laohu8.com/highlight/detail?id=2678192910","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678192910?lang=en_us&edition=fundamental","pubTime":"2026-10-26 23:10","pubTimestamp":1793027413,"startTime":"0","endTime":"0","summary":"Shares of drug developer Oric Pharmaceuticals (ORIC) are falling after competitor Johnson & Johnson (JNJ) presented data about its own potential dr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oric-pharmaceuticals-drops-after-jj-presents-prostate-cancer-drug-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oric-pharmaceuticals-drops-after-jj-presents-prostate-cancer-drug-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","IE00B3PB1722.GBP","LU1074936037.SGD","IYH","BK4550","LU1894683348.USD","FHLC","LU0289739699.SGD","LU1291159041.SGD","LU0820561909.HKD","LU2417539215.USD","LU2756315318.SGD","LU0122379950.USD","LU0889566641.SGD","LU0124676726.USD","GDOC","IHE","TRUH","IXJ","LU1261432733.SGD","IE00B7SZLL34.SGD","IE00BGHQF631.EUR","LU2236285917.USD","LU0098860793.USD","MEDX","FTXH","VHT","LU2129689514.USD","LU0820562030.AUD","PJP","LU1121112475.USD","LU1023059063.AUD","LU1430594728.SGD","IE0002141913.USD","LU1043141123.HKD","LU0912757837.SGD","LU0820561818.USD","LU1228905540.USD","ORIC","IE000BZT7R73.USD","LU0472753341.HKD","IE00BKVL7J92.USD","JDOC","LU0985320562.USD","BK4559","JNJ","LU1059921491.USD","RXL","XLV","IE00B1BXHZ80.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678116972","title":"Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Oric Pharmaceuticals (ORIC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2678116972","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678116972?lang=en_us&edition=fundamental","pubTime":"2026-10-26 17:50","pubTimestamp":1793008231,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Perspective Therapeutics (CATX) and Oric Pharmaceuti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-perspective-therapeutics-catx-oric-pharmaceuticals-oric-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-perspective-therapeutics-catx-oric-pharmaceuticals-oric-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4588","LABU","ORIC","LU0029874061.USD","BK4139","LU0128526141.USD","CATX","HCSG","BK4581","XBI","BK4137","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677975565","title":"Analysts Are Bullish on Top Healthcare Stocks: Korro Bio (KRRO), Oric Pharmaceuticals (ORIC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2677975565","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677975565?lang=en_us&edition=fundamental","pubTime":"2026-10-23 22:40","pubTimestamp":1792766409,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Korro Bio (KRRO), Oric Pharmaceuticals (ORIC) and De...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-korro-bio-krro-oric-pharmaceuticals-oric-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-korro-bio-krro-oric-pharmaceuticals-oric-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0128526141.USD","XBI","LABU","HCSG","BK4585","BK4139","BK4581","LU0029874061.USD","ORIC","KRRO","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677947600","title":"Oric Pharmaceuticals presents enozertinib data at ESMO Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2677947600","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677947600?lang=en_us&edition=fundamental","pubTime":"2026-10-23 17:20","pubTimestamp":1792747233,"startTime":"0","endTime":"0","summary":"Oric Pharmaceuticals (ORIC) presented data for enozertinib in first-line NSCLC patients with EGFR atypical mutations at ESMO Congress 2026 and anno...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oric-pharmaceuticals-presents-enozertinib-data-at-esmo-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oric-pharmaceuticals-presents-enozertinib-data-at-esmo-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ORIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677945088","title":"ORIC Pharmaceuticals Plans Phase 3 Enozertinib Trial in Lung Cancer for First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2677945088","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677945088?lang=en_us&edition=fundamental","pubTime":"2026-10-23 15:15","pubTimestamp":1792739752,"startTime":"0","endTime":"0","summary":"ORIC Pharmaceuticals plans Phase 3 enozertinib trial in lung cancer for first half of 2027ORIC Pharmaceuticals plans to start Redwood-1, a global Phase 3 trial of enozertinib in first-line EGFR atypic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nNDL2RYNK2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4585","BK4139","NDAQ","IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014013.SGD","SG9999014021.USD","BK4112","IE00BN0W2T93.GBP","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","BK4588","LU2210150020.SGD","IE00BQXX3D17.EUR","LU2095319765.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","IE00BQXX3F31.USD","BCDF","IE00BQXX3C00.GBP","ORIC","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677194508","title":"ORIC Data Suggest Rinzimetostat May Enhance Prostate Cancer Sensitivity to Androgen Receptor Inhibition","url":"https://stock-news.laohu8.com/highlight/detail?id=2677194508","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677194508?lang=en_us&edition=fundamental","pubTime":"2026-10-23 15:15","pubTimestamp":1792739733,"startTime":"0","endTime":"0","summary":"ORIC data suggest rinzimetostat may enhance prostate cancer sensitivity to androgen receptor inhibitionORIC Pharmaceuticals presented preclinical and patient-sample findings at ESMO Congress 2026 supp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nNDL5JFtmw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BCDF","ORIC","LU2210150020.SGD","BK4112","LU0314104364.USD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BN0W2W23.USD","BK4139","IE00BKPKM429.USD","SG9999014013.SGD","LU2095319765.USD","SG9999014021.USD","IE00BQXX3C00.GBP","SG9999014039.USD","SG9999014005.SGD","BK4585","IE00BN0W2T93.GBP","NDAQ","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","BK4588","IE00BN0W2V16.EUR","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677994577","title":"Oric® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L Nsclc Patients with Egfr Atypical Mutations at Esmo Congress 2026 and Plans to Advance Enozertinib into a Global Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2677994577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677994577?lang=en_us&edition=fundamental","pubTime":"2026-10-23 15:15","pubTimestamp":1792739700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nTUA9F7MNV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ORIC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677945778","title":"Oric Pharmaceuticals - Enozertinib Shows Competitive Safety Profile with no Significant Off-Target Toxicity","url":"https://stock-news.laohu8.com/highlight/detail?id=2677945778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677945778?lang=en_us&edition=fundamental","pubTime":"2026-10-23 15:15","pubTimestamp":1792739700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nTUA9F7MNV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ORIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677457729","title":"Oric Pharmaceuticals - Enozertinib Well Tolerated with no Grade 4/5 Traes or Treatment Discontinuations","url":"https://stock-news.laohu8.com/highlight/detail?id=2677457729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677457729?lang=en_us&edition=fundamental","pubTime":"2026-10-23 15:15","pubTimestamp":1792739700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nTUA9F7MNV:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ORIC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677969252","title":"Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Embla Medical hf (OtherOSSFF) and Molina Healthcare (MOH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2677969252","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677969252?lang=en_us&edition=fundamental","pubTime":"2026-10-22 21:50","pubTimestamp":1792677008,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Oric Pharmaceuticals (ORIC), Embla Medical hf (OSSFF) and Molina ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oric-pharmaceuticals-oric-embla-medical-hf-otherossff-and-molina-healthcare-moh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oric-pharmaceuticals-oric-embla-medical-hf-otherossff-and-molina-healthcare-moh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OSSFF","PSCH","BK4581","SG9999014013.SGD","BK4154","SG9999014005.SGD","SG9999014039.USD","XLV","ORIC","XBI","LABU","MOH","BK4532","BK4585","SG9999014021.USD","BK4588","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677060010","title":"Oric Pharmaceuticals CFO Dominic Piscitelli Reports Sale of $189,390.60 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2677060010","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677060010?lang=en_us&edition=fundamental","pubTime":"2026-10-22 05:17","pubTimestamp":1792617479,"startTime":"0","endTime":"0","summary":"Oric Pharmaceuticals CFO Dominic Piscitelli reports sale of $189,390.60 in common sharesOric Pharmaceuticals Chief Financial Officer Dominic Piscitelli sold 14,000 common shares on Oct. 20, 2026, at $","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL6msTJQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Oric Pharmaceuticals CFO Dominic Piscitelli Reports Sale of $189,390.60 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676683008","title":"ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2676683008","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676683008?lang=en_us&edition=fundamental","pubTime":"2026-10-19 20:00","pubTimestamp":1792411200,"startTime":"0","endTime":"0","summary":"Conference call and webcast to take place on Friday, October 23, 2026, at 8:00 a.m. ET Event to feature Dr. Joshua Sabari to discuss enozertinib clinical data and the potential of enozertinib to treat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/19/3383372/0/en/oric-pharmaceuticals-to-host-conference-call-webcast-to-review-enozertinib-data-being-presented-at-esmo-congress-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORIC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.oricpharma.com","stockEarnings":[{"period":"1week","weight":0.0128},{"period":"1month","weight":-0.2569},{"period":"3month","weight":-0.3267},{"period":"6month","weight":-0.0247},{"period":"1year","weight":-0.3108},{"period":"ytd","weight":0.1088}],"compareEarnings":[{"period":"1week","weight":-0.0173},{"period":"1month","weight":-0.0228},{"period":"3month","weight":-0.0249},{"period":"6month","weight":0.0249},{"period":"1year","weight":0.1027},{"period":"ytd","weight":0.1029}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. Its lead product candidate is ORIC-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors. The company's second product candidate is ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. It is also developing multiple precision medicines targeting other cancer resistance mechanisms. The company was founded in 2014 and is headquartered in South San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.039993},{"month":2,"riseRate":0.5,"avgChangeRate":-0.014475},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.092137},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.173514},{"month":5,"riseRate":0.571429,"avgChangeRate":0.047029},{"month":6,"riseRate":0.714286,"avgChangeRate":0.161131},{"month":7,"riseRate":0.428571,"avgChangeRate":0.002728},{"month":8,"riseRate":0.714286,"avgChangeRate":0.102485},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.036648},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.114376},{"month":11,"riseRate":0.571429,"avgChangeRate":0.140859},{"month":12,"riseRate":0.5,"avgChangeRate":0.06155}],"exchange":"NASDAQ","name":"Oric Pharmaceuticals Inc.","nameEN":"Oric Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Oric Pharmaceuticals Inc.(ORIC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Oric Pharmaceuticals Inc.(ORIC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Oric Pharmaceuticals Inc.,ORIC,Oric Pharmaceuticals Inc.股票,Oric Pharmaceuticals Inc.股票老虎,Oric Pharmaceuticals Inc.股票老虎国际,Oric Pharmaceuticals Inc.行情,Oric Pharmaceuticals Inc.股票行情,Oric Pharmaceuticals Inc.股价,Oric Pharmaceuticals Inc.股市,Oric Pharmaceuticals Inc.股票价格,Oric Pharmaceuticals Inc.股票交易,Oric Pharmaceuticals Inc.股票购买,Oric Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Oric Pharmaceuticals Inc.(ORIC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Oric Pharmaceuticals Inc.(ORIC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}